Bharat Biotech gets nod to conduct phase 3, booster trials of intranasal Covid vaccine

New Delhi, Jan 05: The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) has given ‘in principle’ approval to Bharat Biotech for conduct of ‘Phase III superiority study and Phase III booster dose study’ for its intranasal COVID

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News